UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000043740 |
|---|---|
| Receipt number | R000044163 |
| Scientific Title | Elucidation of pathologic condition in patients with cerebrovascular disease or neurodegenerative disease using C-11 flumazenil PET |
| Date of disclosure of the study information | 2021/03/25 |
| Last modified on | 2025/03/29 13:11:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Elucidation of pathologic condition in patients with cerebrovascular disease or neurodegenerative disease using C-11 flumazenil PET
Acronym
Elucidation of pathologic condition in patients with cerebrovascular disease or neurodegenerative disease using C-11 flumazenil PET
Scientific Title
Elucidation of pathologic condition in patients with cerebrovascular disease or neurodegenerative disease using C-11 flumazenil PET
Scientific Title:Acronym
Elucidation of pathologic condition in patients with cerebrovascular disease or neurodegenerative disease using C-11 flumazenil PET
Region
| Japan |
Condition
Condition
Patients with or suspected cerebrovascular disease or neurodegenerative disease
Classification by specialty
| Radiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To elucidate of pathologic condition in disease using C-11 flumazenil PET
Basic objectives2
Others
Basic objectives -Others
To elucidate of pathologic condition
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
SUV in disease using C-11 flumazenil PET
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Diagnosis
Type of intervention
| Medicine |
Interventions/Control_1
PETCT imaging will be performed after injection of C-11 flumazenil.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with or suspected cerebrovascular disease or neurodegenerative disease
Key exclusion criteria
Patient judged unsuitable as a subject by a researcher
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Yoshihiro |
| Middle name | |
| Last name | Nishiyama |
Organization
Faculty of Medicine, Kagawa University
Division name
Department of Radiology
Zip code
761-0793
Address
1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa
TEL
087-898-5111
yamamoto.yuka@kagawa-u.ac.jp
Public contact
Name of contact person
| 1st name | Yuka |
| Middle name | |
| Last name | Yamamoto |
Organization
Faculty of Medicine, Kagawa University
Division name
Department of Radiology
Zip code
761-0793
Address
1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa
TEL
087-898-5111
Homepage URL
yamamoto.yuka@kagawa-u.ac.jp
Sponsor or person
Institute
Kagawa University
Institute
Department
Personal name
Funding Source
Organization
Kagawa University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Faculty of Medicine, Kagawa University
Address
1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa
Tel
087-898-5111
yamamoto.yuka@kagawa-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 03 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Suspended
Date of protocol fixation
| 2020 | Year | 04 | Month | 01 | Day |
Date of IRB
| 2019 | Year | 12 | Month | 16 | Day |
Anticipated trial start date
| 2020 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2030 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 03 | Month | 25 | Day |
Last modified on
| 2025 | Year | 03 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044163
